A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE WITH INSULIN IN PATIENTS WITH TYPE 2 DIABETES ADDING MEALTIME INSULIN TO A BASAL REGIMEN

被引：0

作者：

Kalsekar, A. ^{[1
]}

Bonafede, M. M. ^{[2
]}

Pawaskar, M. D. ^{[1
]}

McGuffie, K. ^{[3
]}

Torres, A.

Kelly, K. R. ^{[1
]}

Curkendall, S.

机构：

[1] Eli Lilly & Co, Indianapolis, IN 46285 USA

[2] Thomson Reuters, Cambridge, MA USA

[3] Thomson Reuters, Washington, DC USA

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 07期

关键词：

D O I：

10.1016/S1098-3015(10)75042-7

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A413 / A413

页数：1

共 50 条

[31] COST-EFFECTIVENESS ANALYSIS OF ADDING PIOGLITAZONE TO INSULIN REGIMEN IN TYPE2 DIABETES IN IRAN
Davari, M.
Khorasani, E.
Shojaei, Savari R.
Sari, Akbari A.
Saiyarsarai, P.
VALUE IN HEALTH, 2018, 21 : S129 - S130
[32] Efficacy of treatment with a basal-prandial insulin regimen in patients with type 2 diabetes mellitus previously treated with premixed insulin
Javier Garcia-Soidan, Francisco
AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 12 - 18
[33] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
Dailey, G
Rosenstock, J
Moses, R
Ways, K
DIABETOLOGIA, 2004, 47 : A265 - A266
[34] Glycemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with type 2 diabetes
Dailey, G
Rosenstock, J
Moses, R
Ways, K
DIABETES, 2004, 53 : A121 - A121
[35] Patient Reported Outcomes in Adults with Type 2 Diabetes Using Mealtime AFRESA™ (Inhaled Technosphere® Insulin) and Basal Insulin Versus Premixed Insulin
Howard, Campbell P.
Rubin, Richard R.
Peyrot, Mark
DIABETES, 2009, 58 : A148 - A148
[36] Predictors of Adherence and Persistence to Basal Insulin Therapy in Adults with Type 2 Diabetes
Aroda, Vanita R.
Nielsen, Nick F.
Mangla, Kamal K.
Wang, Yi
Namvar, Tarlan
Rajpura, Jigar R.
DIABETES, 2023, 72
[37] Postprandial increase in IL 6 and TNFα is reduced by a basal plus prandial insulin regimen compared with a basal insulin regimen in type 2 diabetes (T2D) patients
Tan, Meng H.
Brown, W. Virgil
Goldberg, Ronald B.
Ceriello, Antonio
Beisswenger, Paul J.
Le, Ngoc-Anh
Sarwat, Samiha
Jones, Cate A.
Milicevic, Zvonko
Robbins, David C.
DIABETES, 2007, 56 : A174 - A174
[38] Patient-Reported Outcomes in Adults with Type 2 Diabetes Using Mealtime Inhaled Technosphere Insulin and Basal Insulin Versus Premixed Insulin
Peyrot, Mark
Rubin, Richard R.
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (12) : 1201 - 1206
[39] Human insulin analog, insulin aspart, is a mealtime insulin comparable to human insulin in type 2 diabetes.
McGill, J
Raskin, P
Kilo, C
Boss, AH
Kamp, NM
DIABETOLOGIA, 1999, 42 : A238 - A238
[40] A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS - THE GINGER STUDY
Tilling, C.
Vora, J.
Keech, M.
VALUE IN HEALTH, 2011, 14 (03) : A94 - A94

← 1 2 3 4 5 →